← Evidence map

ArticleSpringerPlus2014

Pharmaceutical company perspectives on current safety risk communications in Japan.

Hisashi Urushihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 24555168